Results 31 to 40 of about 241,274 (262)

HDAC inhibitors increase NRF2-signaling in tumour cells and blunt the efficacy of co-adminstered cytotoxic agents [PDF]

open access: yes, 2014
The NRF2 signalling cascade provides a primary response against electrophilic chemicals and oxidative stress. The activation of NRF2-signaling is anticipated to have adverse clinical consequences; NRF2 is activated in a number of cancers, additionally ...
A Kenneth MacLeod   +17 more
core   +1 more source

Combination chemotherapy with anticancer agents and OK-432

open access: yes, 1974
Antitumor effects of the combination chemotherapy with hemolytic streptococcus preparation, OK-432, and various anticancer agents were observed on experimental tumors and human cancers.
Sugiyama, Motoharu   +6 more
core   +1 more source

CHAPTER 5. Anticancer Gold Compounds

open access: yes, 2019
The use of gold in medicine has a long history that dates back to ancient times. In modern medicine, gold compounds have been applied as anti-inflammatory agents for the treatment of rheumatoid arthritis.
Chun-Nam Lok   +5 more
core   +1 more source

Copper complexes as anticancer agents

open access: yes, 2009
Metal-based antitumor drugs play a relevant role in antiblastic chemotherapy. Cisplatin is regarded as one of the most effective drugs, even if severe toxicities and drug resistance phenomena limit its clinical use.
F. TISATO   +3 more
core   +2 more sources

Anticancer Agents Targeted to Sirtuins

open access: yesMolecules, 2014
Sirtuins are nicotinamide adenine dinucleotide+-dependent deacetylases of which there are seven isoforms (SIRT1–7). Sirtuin activity is linked to gene expression, lifespan extension, neurodegeneration, and age-related disorders.
Tomohiro Kozako   +5 more
doaj   +1 more source

A comprehensive review on pyrazoline based heterocyclic hybrids as potent anticancer agents

open access: yesEuropean Journal of Medicinal Chemistry Reports, 2022
Cancer is one of the leading causes of death globally, around 10 million deaths are reported every year due to cancer. Some clinically approved anticancer drugs play a riveting role in its treatment. Still, due to the severe emergence of drug resistance,
Kashif Haider   +3 more
doaj   +1 more source

The universe of normal and cancer cell line responses to anticancer treatment: Lessons for cancer therapy

open access: yes, 2011
According to the Surveillance Epidemiology and End Results report, 1,479,350 men and women will be diagnosed with and 562,340 will die of cancer of all sites in 2009, indicating that about 40% of the cancer patients do not respond well to current ...
Alexei Vazquez
core   +1 more source

The contrasting activity of iodido versus chlorido ruthenium and osmium arene azo- and imino-pyridine anticancer complexes : control of cell selectivity, cross-resistance, p53 dependence, and apoptosis pathway [PDF]

open access: yes, 2013
Organometallic half-sandwich complexes [M(p-cymene)(azo/imino-pyridine)X]+ where M = RuII or OsII and X ═ Cl or I, exhibit potent antiproliferative activity toward a range of cancer cells.
Sadler, P. J.   +2 more
core   +1 more source

The development of a novel antioxidant-based antiemetic drug to improve quality of life during anticancer therapy

open access: yesBiochemistry and Biophysics Reports, 2022
Anticancer agents can effectively treat several types of cancers but are often limited in clinical settings due to various adverse effects. In particular, nausea and vomiting are serious side effects that markedly reduce the patients' quality of life ...
Hiroto Yanagawa   +4 more
doaj   +1 more source

Trastuzumab-Conjugated pH-Sensitive Micelles Exhibit Antitumor Activity and Induce Mesenchymal-to-Epithelial Transition in Triple-Negative Breast Cancer Cell Lines

open access: yesPharmaceutics
Background: Despite improved knowledge on cancer prevention, progression, and treatment, the incidence of cancer is still increasing. Patients with highly aggressive triple-negative breast cancer benefit from chemotherapy as the only systemic therapeutic
Crina Elena Tiron   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy